Protein-Protein Interactions and Cancer: Targeting the Central Dogma
The DOI matches its Crossref record.
Abstract
Between 40,000 and 200,000 protein-protein interactions have been predicted to exist within the human interactome. As these interactions are of a critical nature in many important cellular functions and their dysregulation is causal of disease, the modulation of these binding events has emerged as a leading, yet difficult therapeutic arena. In particular, the targeting of protein-protein interactions relevant to cancer is of fundamental importance as the tumor-promoting function of several aberrantly expressed proteins in the cancerous state is directly resultant of its ability to interact with a protein- binding partner. Of significance, these protein complexes play a crucial role in each of the steps of the central dogma of molecular biology, the fundamental processes of genetic transmission. With the many important discoveries being made regarding the mechanisms of these genetic process, the identification of new chemical probes are needed to better understand and validate the druggability of protein-protein interactions related to the central dogma. In this review, we provide an overview of current small molecule-based protein-protein interaction inhibitors for each stage of the central dogma: transcription, mRNA splicing and translation. Importantly, through our analysis we have uncovered a lack of necessary probes targeting mRNA splicing and translation, thus, opening up the possibility for expansion of these fields. Keywords: Cancer, mRNA splicing, protein-protein interactions, small molecules, transcription, translation, human interactome, genetic transmission, molecular biology, DNA, ribosome, non-peptidic molecules, embryogenesis, cell-to-cell communication, receptor-ligand interactions, signal transduction pathways, gene transcription, metabolism, homeostasis, hot spot, RNA polymerase II, co-repressors, chromatin re-modelers, histone acetylases, kinases, methylases, p53(H/M)DM2 Inhibitors, human tumors, tumor suppressor, apoptosis, DNA repair, tumorigenesis, N-terminal domain, MDM2, chalcone, ELISA, NMR, MCF-7, NCI-H446, sulfonamide, pharmacophore, cancer therapy, cis-imidazoline, Nutlin-3, nutlin-type analogue 7, benzodiazepinedione, TDP665759, doxorubicin, A375 melanoma cells, pentanoic acid, MI-43, LNCaP cells, tissue sarcoma, cyclin E, catenin, oncogene addiction, DMSO, Microdochium caespitosum, helix-loop-helix leucine zipper, Burkitt's lymphoma, colorectal cancers, colon carcinomas, CACGTG, zincfinger, FRET-based assay, mobility-shift assay, mycmicin-2, TCF-catenin, catenin CREB-binding protein, HIF p300, KID KIX, Runx1 CBF, EWS-FLI1 RNA helicase A, Hsp90 BCL-6, T-cell factor, APC complex, SW620 xenograft, acute myeloid leukemia, serine residue, Chaetomium, Core binding factor, coiled-coil domain, EWS-FLI1 RNA helicase, Topoisomerase I Kinase, histone acetylation, eIF4E Interactions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oncogenic protein interfaces: small molecules, big challenges
Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312
Labbé, C. M., Laconde, G., Kuenemann, M. A., Villoutreix, B. O., & Sperandio, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.003 · Cited by 104
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
Brito, D. M. S., Lima, O. G., Mesquita, F. P., da Silva, E. L., de Moraes, M. E. A., Burbano, R. M. R., Montenegro, R. C., & Souza, P. F. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092303 · Cited by 6
(2025) · doi:10.1038/s41467-024-54176-3 · Cited by 4
Metadata
- Authors
- L. Garner, A., & D. Janda, K.
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-02-01
- Volume
- 11
- Issue
- 3
- Pages
- 258-280
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W2034694321
- Cited by
- 77
- References
- 0
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein-Protein Interactions and Cancer: Targeting the Central Dogma. https://app.cochat.ai/papers/10.2174/156802611794072614
- The paper
- L. Garner, A., & D. Janda, K. (2011). Protein-Protein Interactions and Cancer: Targeting the Central Dogma. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/156802611794072614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.